PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1974 June; 67(6 Pt 2): 557–562.
PMCID: PMC1645576

The Immunological Basis of Glomerulonephritis

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH. Deficiency of C3 inactivator in man. J Immunol. 1971 Jul;107(1):19–27. [PubMed]
  • Agnello V, De Bracco MM, Kunkel HG. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol. 1972 Mar;108(3):837–840. [PubMed]
  • Alper CA, Bloch KJ, Rosen FS. Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. N Engl J Med. 1973 Mar 22;288(12):601–606. [PubMed]
  • Alper CA, Colten HR, Rosen FS, Rabson AR, Macnab GM, Gear JS. Homozygous deficiency of C3 in a patient with repeated infections. Lancet. 1972 Dec 2;2(7788):1179–1181. [PubMed]
  • Alper CA, Rosen FS. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients. J Clin Invest. 1967 Dec;46(12):2021–2034. [PMC free article] [PubMed]
  • BERGER J, GALLE P. D'EP OTS DENSES AU SEIN DES MEMBRANES BASALES DU REIN. ETUDE EN MICROSCOPIES OPTIQUE ET 'ELECTRONIQUE. Presse Med. 1963 Nov 20;71:2351–2354. [PubMed]
  • Controlled trial of azathioprine and prednisone in chronic renal disease. Report by Medical Research Council Working Party. Br Med J. 1971 May 1;2(5756):239–241. [PMC free article] [PubMed]
  • Black JA, Challacombe DN, Ockenden BG. Nephrotic syndrome associated with bacteraemia after shunt operations for hydrocephalus. Lancet. 1965 Nov 6;2(7419):921–924. [PubMed]
  • Cameron JS, Glasgow EF, Ogg CS, White RH. Membranoproliferative glomerulonephritis and persistent hypocomplementaemia. Br Med J. 1970 Oct 3;4(5726):7–14. [PMC free article] [PubMed]
  • COCHRANE CG, UNANUE ER, DIXON FJ. A ROLE OF POLYMORPHONUCLEAR LEUKOCYTES AND COMPLEMENT IN NEPHROTOXIC NEPHRITIS. J Exp Med. 1965 Jul 1;122:99–116. [PMC free article] [PubMed]
  • Combes B, Shorey J, Barrera A, Stastny P, Eigenbrodt EH, Hull AR, Carter NW. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet. 1971 Jul 31;2(7718):234–237. [PubMed]
  • DIXON FJ, FELDMAN JD, VAZQUEZ JJ. Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med. 1961 May 1;113:899–920. [PMC free article] [PubMed]
  • Evans DJ, Williams DG, Peters DK, Sissons JG, Boulton-Jones JM, Ogg CS, Cameron JS, Hoffbrand BI. Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J. 1973 Aug 11;3(5875):326–328. [PMC free article] [PubMed]
  • Germuth FG, Jr, Senterfit LB, Pollack AD. Immune complex disease. I. Experimental acute and chronic glomerulonephritis. Johns Hopkins Med J. 1967 Apr;120(4):225–251. [PubMed]
  • Gewurz H, Pickering RJ, Mergenhagen SE, Good RA. The complement profile in acute glomerulonephritis systemic lupus erythematosus and hypocomplementemic chronic glomerulonephritis. Contrasts and experimental correlations. Int Arch Allergy Appl Immunol. 1968;34(6):556–570. [PubMed]
  • GOTOFF SP, FELLERS FX, VAWTER GF, JANEWAY CA, ROSEN FS. THE BETA-1C GLOBULIN IN CHILDHOOD NEPHROTIC SYNDROME: LABORATORY DIAGNOSIS OF PROGRESSIVE GLOMERULONEPHRITIS. N Engl J Med. 1965 Sep 2;273:524–529. [PubMed]
  • Gutman RA, Striker GE, Gilliland BC, Cutler RE. The immune complex glomerulonephritis of bacterial endocarditis. Medicine (Baltimore) 1972 Jan;51(1):1–25. [PubMed]
  • Hamburger J. The immunological follow up of renal allograft recipients. Proc R Soc Med. 1972 Dec;65(12):1051–1056. [PMC free article] [PubMed]
  • Henson PM, Cochrane CG. Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets. J Exp Med. 1971 Mar 1;133(3):554–571. [PMC free article] [PubMed]
  • Pickering RJ, Herdman RC, Michael AF, Vernier RL, Gewurz H, Fish AJ, Good RA. Chronic glomerulonephritis associated with low serum complement activity (chronic hypocomplementemic glomerulonephritis). Medicine (Baltimore) 1970 May;49(3):207–226. [PubMed]
  • Hunsicker LG, Ruddy S, Carpenter CB, Schur PH, Merrill JP, Müller-Eberhard HJ, Austen KF. Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation. N Engl J Med. 1972 Oct 26;287(17):835–840. [PubMed]
  • Koffler D, Schur PH, Kunkel HG. Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med. 1967 Oct 1;126(4):607–624. [PMC free article] [PubMed]
  • Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967 Dec 1;126(6):989–1004. [PMC free article] [PubMed]
  • Loughridge LW, Lewis MG. Nephrotic syndrome in malignant disease of non-renal origin. Lancet. 1971 Feb 6;1(7693):256–258. [PubMed]
  • Mauer SM, Sutherland DE, Howard RJ, Fish AJ, Najarian JS, Michael AF. The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med. 1973 Mar 1;137(3):553–570. [PMC free article] [PubMed]
  • Moncada B, Day NK, Good RA, Windhorst DB. Lupus-erythematosus-like syndrome with a familial defect of complement. N Engl J Med. 1972 Mar 30;286(13):689–693. [PubMed]
  • Naish P, Penn GB, Evans DJ, Peters DK. The effect of defibrination on nephrotoxic serum nephritis in rabbits. Clin Sci. 1972 May;42(5):643–646. [PubMed]
  • Celada F. Quantitative studies of the adoptive immunological memory in mice. I. An age-dependent barrier to syngeneic transplantation. J Exp Med. 1966 Jul 1;124(1):1–14. [PMC free article] [PubMed]
  • Pepys MB. Role of complement in induction of the allergic response. Nat New Biol. 1972 May 31;237(74):157–159. [PubMed]
  • Peters DK, Martin A, Weinstein A, Cameron JS, Barratt TM, Ogg CS, Lachmann PJ. Complement studies in membrano-proliferative glomerulonephritis. Clin Exp Immunol. 1972 Jul;11(3):311–320. [PubMed]
  • Peters DK, Charlesworth JA, Sissons JG, Williams DG, Boulton-Jones JM, Evans DJ, Kourilsky O, Morel-Maroger L. Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet. 1973 Sep 8;2(7828):535–538. [PubMed]
  • Pickering RJ, Michael AF, Jr, Herdman RC, Good RA, Gewurz H. The complement system in chronic glomerulonephritis: three newly associated aberrations. J Pediatr. 1971 Jan;78(1):30–43. [PubMed]
  • Pincus T, Haberkern R, Christian CL. Experimental chronic glomerulitis. J Exp Med. 1968 Apr 1;127(4):819–832. [PMC free article] [PubMed]
  • Soothill JF, Steward MW. The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol. 1971 Aug;9(2):193–199. [PubMed]
  • Spitzer RE, Vallota EH, Forristal J, Sudora E, Stitzel A, Davis NC, West CD. Serum C'3 lytic system in patients with glomerulonephritis. Science. 1969 Apr 25;164(3878):436–437. [PubMed]
  • Sussman M, Jones JH, Almeida JD, Lachmann PJ. Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum. Clin Exp Immunol. 1973 Aug;14(4):531–539. [PubMed]
  • Tan EM, Schur PH, Carr RI, Kunkel HG. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1966 Nov;45(11):1732–1740. [PMC free article] [PubMed]
  • Thompson RA. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis. Immunology. 1972 Jan;22(1):147–158. [PubMed]
  • Treser G, Semar M, Ty A, Agel I, Franklin MA, Lange K. Partial characterization of antigenic streptococcal plasma membrane components in acute glomerulonephritis. J Clin Invest. 1970 Apr;49(4):762–768. [PMC free article] [PubMed]
  • Vallota EH, Forristal J, Spitzer RE, Davis NC, West CD. Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis. J Clin Invest. 1971 Mar;50(3):552–558. [PMC free article] [PubMed]
  • VASSALLI P, MCCLUSKEY RT. THE PATHOGENIC ROLE OF THE COAGULATION PROCESS IN RABBIT MASUGI NEPHRITIS. Am J Pathol. 1964 Oct;45:653–677. [PubMed]
  • Ward PA, Kibukamusoke JW. Evidence for soluble immune complexes in the pathogenesis of the glomerulonephritis of quartan malaria. Lancet. 1969 Feb 8;1(7589):283–285. [PubMed]
  • West CD, McAdams AJ. Serum beta-1C globulin levels in persistent glomerulonephritis with low serum complement: variability unrelated to clinical course. Nephron. 1970;7(3):193–202. [PubMed]
  • WEST CD, NORTHWAY JD, DAVIS NC. SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS. J Clin Invest. 1964 Aug;43:1507–1517. [PMC free article] [PubMed]
  • Williams DG, Lachmann PJ, Charlesworth JA, Peters DK. Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet. 1973 Mar 3;1(7801):447–449. [PubMed]
  • WILLIAMS RC, Jr, KUNKEL HG. Rheumatoid factor, complement, and conglutinin aberrations in patients with subacute bacterial endocarditis. J Clin Invest. 1962 Mar;41:666–675. [PMC free article] [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press